Similarly, the higher sensitivity to FGFR-inhibitors observed in FGFR3-fusion expressing cancer cells, compared to FGFR3 point mutations [19], could be better understood by comprehensive analyses and comparison of cellular networks linked to these different FGFR3 aberrations. Here, FGFR3 is linked to cancer.